Literature DB >> 26464661

Survivin contributes to the progression of diabetic retinopathy through HIF-1α pathway.

Ningning Liu1, Ning Zhao1, Lei Chen1, Na Cai1.   

Abstract

Hypoxia plays a critical role in the formation of diabetic retinopathy (DR). Hypoxia inducible factor-1α (HIF-1α) and survivin are upregulated following hypoxia, and contribute to the angiogenesis in cancer. The goal of our study was to investigate if the expression of HIF-1α and survivin is related to the retinal vascular change of rats with different stages of diabetes mellitus (DM). Wistar rats were randomly divided into DM for 1 month (DM1) group, DM3, DM6 group and normal control group. Streptozotocin (STZ) was used to induce diabetic rat models. Retinal vascular digest preparation was taken to observe the change of retinal microvessels. The expression of HIF-1α and survivin was determined by real-time PCR and Western blot. In DM3 group, capillaries became circuitous and irregular. Acellular capillary were detected in DM6 group. In the same time, the number of pericytes significantly decreased in DM3 and DM6 groups. The expressions of HIF-1α were more increased in the DM3 and DM6 groups. However, the expressions of survivin only were upregulated in DM6 group .These data suggest that HIF-1α induced the upregulation of survivin in the early stage of DR. Survivin contributed to the development and progression of DR through the HIF-1α pathway and become an important progression marker of DR.

Entities:  

Keywords:  Diabetic retinopathy; hypoxia inducible factor-1α; survivin

Mesh:

Substances:

Year:  2015        PMID: 26464661      PMCID: PMC4583893     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  26 in total

Review 1.  Ocular neovascularization: basic mechanisms and therapeutic advances.

Authors:  Michael Dorrell; Hannele Uusitalo-Jarvinen; Edith Aguilar; Martin Friedlander
Journal:  Surv Ophthalmol       Date:  2007-01       Impact factor: 6.048

Review 2.  Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics.

Authors:  Alain C Mita; Monica M Mita; Steffan T Nawrocki; Francis J Giles
Journal:  Clin Cancer Res       Date:  2008-08-15       Impact factor: 12.531

Review 3.  Transcriptional regulation of the survivin gene.

Authors:  Romain Boidot; Frédérique Végran; Sarab Lizard-Nacol
Journal:  Mol Biol Rep       Date:  2013-11-07       Impact factor: 2.316

4.  HIF-1α confers resistance to induced stress in bone marrow-derived mesenchymal stem cells.

Authors:  Ali Asghar Kiani; Ahmad Kazemi; Rahele Halabian; Mahshid Mohammadipour; Ali Jahanian-Najafabadi; Mehryar Habibi Roudkenar
Journal:  Arch Med Res       Date:  2013-03-21       Impact factor: 2.235

Review 5.  Prevalence of diabetic retinopathy in various ethnic groups: a worldwide perspective.

Authors:  Sobha Sivaprasad; Bhaskar Gupta; Roxanne Crosby-Nwaobi; Jennifer Evans
Journal:  Surv Ophthalmol       Date:  2012-04-28       Impact factor: 6.048

6.  HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin.

Authors:  Masanobu Morita; Osamu Ohneda; Toshiharu Yamashita; Satoru Takahashi; Norio Suzuki; Osamu Nakajima; Shimako Kawauchi; Masatsugu Ema; Shigeki Shibahara; Tetsuo Udono; Koji Tomita; Makoto Tamai; Kazuhiro Sogawa; Masayuki Yamamoto; Yoshiaki Fujii-Kuriyama
Journal:  EMBO J       Date:  2003-03-03       Impact factor: 11.598

7.  The effects of β-elemene on the expression of mTOR, HIF-1A, survivin in lung adenocarcinoma A549 cell.

Authors:  Enjuan Tong; Yinghui Xu; Guoquan Li; Kun Zou; Lijuan Zou
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-05-16

8.  Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.

Authors:  Farzin Forooghian; Bikul Das
Journal:  Am J Ophthalmol       Date:  2007-09-17       Impact factor: 5.258

9.  Expression and significance of hypoxia-inducible factor-1α and survivin in laryngeal carcinoma tissue and cells.

Authors:  Da-wei Li; Liang Zhou; Bin Jin; Jin Xie; Pin Dong
Journal:  Otolaryngol Head Neck Surg       Date:  2012-10-19       Impact factor: 3.497

10.  Hypoxia-inducible factor-1α polymorphisms and risk of cancer metastasis: a meta-analysis.

Authors:  Qian Zhang; Yan Chen; Bin Zhang; Bin Shi; Wenjun Weng; Zhipeng Chen; Nannan Guo; Yibing Hua; Lingjun Zhu
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

View more
  6 in total

1.  The involvement of the mGluR5-mediated JNK signaling pathway in rats with diabetic retinopathy.

Authors:  Yan-Ni Zhu; Guo-Jin Zuo; Qi Wang; Xiao-Ming Chen; Jin-Kui Cheng; Shu Zhang
Journal:  Int Ophthalmol       Date:  2019-01-03       Impact factor: 2.031

2.  Sanguinarine Reverses Pulmonary Vascular Remolding of Hypoxia-Induced PH via Survivin/HIF1α-Attenuating Kv Channels.

Authors:  Fenling Fan; Yifan Zou; Yousen Wang; Peng Zhang; Xiaoyu Wang; Anthony M Dart; Yuliang Zou
Journal:  Front Pharmacol       Date:  2021-12-24       Impact factor: 5.810

3.  The Role of Survivin and Transcription Factor FOXP1 in Scarring After Glaucoma Surgery.

Authors:  Xiaocong Wang; Zhihua Huang; Lan Zeng; Xin Jin; Ai Yan; Ying Zhang; Wei Tan
Journal:  Transl Vis Sci Technol       Date:  2022-02-01       Impact factor: 3.283

4.  Molecular mechanism of the role of carbamyl erythropoietin in treating diabetic retinopathy rats.

Authors:  Xuegu Xu; Yonghao Cai; Yinfei Yu
Journal:  Exp Ther Med       Date:  2018-05-14       Impact factor: 2.447

5.  GLP-1 Treatment Improves Diabetic Retinopathy by Alleviating Autophagy through GLP-1R-ERK1/2-HDAC6 Signaling Pathway.

Authors:  Xiangsheng Cai; Jingjing Li; Mingzhu Wang; Miaoqin She; Yongming Tang; Jinlong Li; Hongwei Li; Hongxiang Hui
Journal:  Int J Med Sci       Date:  2017-09-19       Impact factor: 3.738

6.  Uncovering the protective mechanism of Taohong Siwu decoction against diabetic retinopathy via HIF-1 signaling pathway based on network analysis and experimental validation.

Authors:  Lei Wang; Shuyan Li; Leilei Wang; Kai Lin; Jialun Du; Wanhong Miao; Lei Zhang
Journal:  BMC Complement Med Ther       Date:  2020-10-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.